Immunization Division, Ministry of Health & Family Welfare, Government of India, New Delhi, India.
John Snow India, Immunization Technical Support Unit (ITSU), New Delhi, India.
Hum Vaccin Immunother. 2022 Dec 31;18(1):2009289. doi: 10.1080/21645515.2021.2009289. Epub 2021 Dec 14.
The electronic vaccine intelligence network (eVIN) was introduced by India's Ministry of Health and Family Welfare in 12 states and was implemented by the United Nations Development Programme through the Gavi health system strengthening support during 2014-17 to replace the traditional paper-based cold-chain management system with an electronic vaccine logistics management system. An economic assessment was conducted as part of the overall assessment of eVIN. The objective of the economic assessment was to conduct a return on investment analysis of eVIN implementation. Return on investment was defined as the ratio of total benefits (savings) from eVIN to total investment in eVIN. All costs were calculated in 2020 prices and reported in Indian rupees (1 US dollar = INR 74.132). A one-rupee investment in eVIN led to a return of INR 0.52 for traditional vaccines. The highest cost savings from eVIN was from better vaccine stock management. When same percentage of savings from the new vaccines were incorporated into the analysis, one-rupee investment in eVIN led to a return of INR 1.41. In the future, when only recurrent costs will exist, the return from eVIN will be even higher: a one-rupee investment in eVIN will yield a return of INR 2.93. The assessment of eVIN showed promising results in streamlining the vaccine flow network and ensuring equity in vaccine stock management along with good return on investment; hence, there was a rapid expansion of eVIN in all 731 districts across 36 states and union territories in the country.
电子疫苗智能网络(eVIN)由印度卫生和家庭福利部在 12 个邦推出,并由联合国开发计划署通过全球疫苗免疫联盟卫生系统加强支持在 2014-17 年期间实施,以电子疫苗物流管理系统取代传统的纸质冷链管理系统。作为 eVIN 全面评估的一部分,进行了经济评估。经济评估的目的是对 eVIN 实施进行投资回报分析。投资回报率被定义为 eVIN 实施的总收益(节省)与 eVIN 总投资的比率。所有成本均按 2020 年价格计算,并以印度卢比(1 美元=74.132 印度卢比)报告。在 eVIN 上投资 1 卢比可带来传统疫苗 0.52 卢比的回报。eVIN 最大的节省成本来自更好的疫苗库存管理。当将新疫苗的相同百分比节省纳入分析时,在 eVIN 上投资 1 卢比可带来 1.41 卢比的回报。在未来,当仅存在经常性成本时,eVIN 的回报将更高:在 eVIN 上投资 1 卢比将带来 2.93 卢比的回报。eVIN 的评估结果表明,在简化疫苗流动网络和确保疫苗库存管理公平性以及良好的投资回报方面取得了有希望的结果;因此,eVIN 在该国所有 36 个邦和联邦属地的 731 个地区迅速扩大。